- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
100
Companies with a Value score of at least 3, ordered by Value score
100 companies
Shanghai Junshi Biosciences
Market Cap: HK$42.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.
1877
HK$29.66
7D
-7.9%
1Y
157.9%
BeOne Medicines
Market Cap: HK$36.2b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
6160
HK$196.70
7D
-1.0%
1Y
57.9%
Grand Pharmaceutical Group
Market Cap: HK$29.8b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$8.50
7D
-3.6%
1Y
87.2%
Shanghai Junshi Biosciences
Market Cap: HK$42.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.
1877
HK$29.66
7D
-7.9%
1Y
157.9%
HUTCHMED (China)
Market Cap: HK$2.0b
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.
13
HK$25.08
7D
-9.1%
1Y
-9.5%
Consun Pharmaceutical Group
Market Cap: HK$14.1b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$16.58
7D
4.0%
1Y
155.1%
China Shineway Pharmaceutical Group
Market Cap: HK$6.2b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.23
7D
-2.8%
1Y
-1.2%
China Shineway Pharmaceutical Group
Market Cap: HK$6.2b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.23
7D
-2.8%
1Y
-1.2%
China Traditional Chinese Medicine Holdings
Market Cap: HK$12.6b
China Traditional Chinese Medicine Holdings Co.
570
HK$2.50
7D
12.6%
1Y
-42.3%
HUTCHMED (China)
Market Cap: HK$2.0b
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.
13
HK$25.08
7D
-9.1%
1Y
-9.5%
United Laboratories International Holdings
Market Cap: HK$30.1b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$15.24
7D
-5.0%
1Y
71.4%
Essex Bio-Technology
Market Cap: HK$3.0b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$5.25
7D
-1.7%
1Y
130.3%
WuXi AppTec
Market Cap: HK$305.4b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
2359
HK$109.20
7D
-3.9%
1Y
167.6%
China Traditional Chinese Medicine Holdings
Market Cap: HK$12.6b
China Traditional Chinese Medicine Holdings Co.
570
HK$2.50
7D
12.6%
1Y
-42.3%
Grand Pharmaceutical Group
Market Cap: HK$29.8b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$8.50
7D
-3.6%
1Y
87.2%
United Laboratories International Holdings
Market Cap: HK$30.1b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$15.24
7D
-5.0%
1Y
71.4%
Shanghai Junshi Biosciences
Market Cap: HK$42.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.
1877
HK$29.66
7D
-7.9%
1Y
157.9%
China Shineway Pharmaceutical Group
Market Cap: HK$6.2b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.23
7D
-2.8%
1Y
-1.2%
China Traditional Chinese Medicine Holdings
Market Cap: HK$12.6b
China Traditional Chinese Medicine Holdings Co.
570
HK$2.50
7D
12.6%
1Y
-42.3%
WuXi AppTec
Market Cap: HK$305.4b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
2359
HK$109.20
7D
-3.9%
1Y
167.6%
BeOne Medicines
Market Cap: HK$36.2b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
6160
HK$196.70
7D
-1.0%
1Y
57.9%
United Laboratories International Holdings
Market Cap: HK$30.1b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$15.24
7D
-5.0%
1Y
71.4%
BeOne Medicines
Market Cap: HK$36.2b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
6160
HK$196.70
7D
-1.0%
1Y
57.9%
WuXi AppTec
Market Cap: HK$305.4b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
2359
HK$109.20
7D
-3.9%
1Y
167.6%
HUTCHMED (China)
Market Cap: HK$2.0b
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.
13
HK$25.08
7D
-9.1%
1Y
-9.5%
Grand Pharmaceutical Group
Market Cap: HK$29.8b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$8.50
7D
-3.6%
1Y
87.2%
Shanghai Haohai Biological Technology
Market Cap: HK$11.9b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$27.30
7D
-2.9%
1Y
-12.6%
Zai Lab
Market Cap: HK$3.6b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
9688
HK$25.26
7D
-0.2%
1Y
61.1%
Genscript Biotech
Market Cap: HK$35.1b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$16.06
7D
-5.5%
1Y
48.7%
JBM (Healthcare)
Market Cap: HK$2.5b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$3.01
7D
-1.3%
1Y
220.2%
3SBio
Market Cap: HK$72.0b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$30.10
7D
-3.5%
1Y
416.3%
PuraPharm
Market Cap: HK$177.8m
An investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally.
1498
HK$0.45
7D
0%
1Y
-32.8%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.2b
Manufactures and distributes Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$2.17
7D
0%
1Y
65.6%
CanSino Biologics
Market Cap: HK$16.4b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$49.00
7D
-7.9%
1Y
133.3%
Sanai Health Industry Group
Market Cap: HK$64.2m
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
1889
HK$0.42
7D
-4.5%
1Y
83.4%
Shanghai Haohai Biological Technology
Market Cap: HK$11.9b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$27.30
7D
-2.9%
1Y
-12.6%